[N(CH2CH2OH)3]2NI(2+).[OOCCH2SC6H4CL-4)2];BIS-[(TRIS-2-HYDROXYETHYL)-AMMONIUM]-NICKEL(II)-DI-(4-CHLOROPHENYLSULFANYL)-ACETATE
Compound with spectra: 1 NMR
![[N(CH2CH2OH)3]2NI(2+).[OOCCH2SC6H4CL-4)2];BIS-[(TRIS-2-HYDROXYETHYL)-AMMONIUM]-NICKEL(II)-DI-(4-CHLOROPHENYLSULFANYL)-ACETATE](/api/compound/5K7D1kkPNXe.png?ph=true&h=300&w=458 "[N(CH2CH2OH)3]2NI(2+).[OOCCH2SC6H4CL-4)2];BIS-[(TRIS-2-HYDROXYETHYL)-AMMONIUM]-NICKEL(II)-DI-(4-CHLOROPHENYLSULFANYL)-ACETATE")
| SpectraBase Compound ID | 5K7D1kkPNXe |
|---|---|
| InChI | InChI=1S/2C8H7ClO2S.2C6H13NO3.Ni/c2*9-6-1-3-7(4-2-6)12-5-8(10)11;2*8-4-1-7(2-5-9)3-6-10;/h2*1-4H,5H2,(H,10,11);2*8H,1-6H2;/q;;2*-2;+6/p-2 |
| InChIKey | SUOSDDJHNCISSI-UHFFFAOYSA-L |
| Mol Weight | 756.34 g/mol |
| Molecular Formula | C28H38Cl2N2NiO10S2 |
| Exact Mass | 754.069835 g/mol |
| Parent InChIKey | UWLQDEQOLXHJOD-UHFFFAOYSA-M |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
1-{[(p-CHLOROPHENYL)THIO]ACETYL}-4-(2-NITRO-alpha,alpha,alpha-TRIFLUORO-p-TOLYL)PIPERAZINE
2-bromophenyl 4-(3,4-dihydro-2(1H)-isoquinolinylcarbonyl)benzyl ether
2-(3'-Chloronaphthalen-2'-yl)-1H-benzoimidazole
2-(p-ethoxyphenyl)-4H-3,1-benzoxazin-4-one
1-phenylpyrazole-4,5-dicarboxylic acid
benzamide, 2-bromo-N-[(Z)-1-(4-morpholinylcarbonyl)-2-phenylethenyl]-
Isoquinoline, 3,4-dihydro-1,4-dimethyl-6-(phenylmethoxy)-
1H-indene-1,3(2H)-dione, 2-[[3-bromo-4-(dimethylamino)phenyl]methylene]-
4-bromo-2-[3-oxo-1-phenyl-3-(1-pyrrolidinyl)propyl]phenol
phenol, 4-bromo-2-[3-(4-morpholinyl)-3-oxo-1-phenylpropyl]-
| Title | Journal or Book | Year |
|---|---|---|
| Reaction of pharmacological active tris-(2-hydroxyethyl)ammonium 4-chlorophenylsulfanylacetate with ZnCl2 or NiCl2: first conversion of a protic ionic liquid into metallated ionic liquid | Chemistry Central Journal | 2013 |